HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shiv Saidha Selected Research

Ganglion Cysts (Ganglion)

1/2022The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis.
1/2022Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
1/2022Longitudinal Retinal Changes in MOGAD.
12/2021Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study.
10/2021Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSD.
1/2021Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis.
1/2021Serum ceramide levels are altered in multiple sclerosis.
10/2020Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning.
1/2020AQP4-IgG and MOG-IgG Related Optic Neuritis-Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis.
1/2020Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shiv Saidha Research Topics

Disease

49Multiple Sclerosis
11/2022 - 01/2011
29Ganglion Cysts (Ganglion)
01/2022 - 02/2011
25Optic Neuritis (Retrobulbar Neuritis)
02/2022 - 02/2012
19Atrophy
11/2022 - 02/2015
6Neuromyelitis Optica (Devic's Disease)
01/2022 - 02/2012
5Macular Edema
10/2019 - 04/2013
4Relapsing-Remitting Multiple Sclerosis
12/2021 - 01/2017
3Optic Nerve Diseases (Optic Neuropathy)
03/2018 - 02/2011
3Retrograde Degeneration
06/2017 - 02/2011
2Disease Progression
11/2022 - 09/2013
2COVID-19
11/2022 - 02/2021
2Inflammation (Inflammations)
03/2022 - 03/2018
2Neurologic Manifestations (Neurological Manifestations)
05/2019 - 09/2013
2Nervous System Diseases (Neurological Disorders)
05/2019 - 01/2018
2Sarcoidosis (Schaumann Disease)
07/2012 - 03/2012
1Stiff-Person Syndrome (Stiff Man Syndrome)
01/2020
1Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
05/2019
1Chronic Progressive Multiple Sclerosis
05/2019
1Epiretinal Membrane (Epiretinal Membranes)
01/2019
1Neuroinflammatory Diseases
03/2018
1Brain Diseases (Brain Disorder)
01/2017
1Edema (Dropsy)
02/2016
1Vision Disorders (Hemeralopia)
02/2015
1Parkinson Disease (Parkinson's Disease)
08/2014
1Cognitive Dysfunction
08/2014
1Tremor (Tremors)
08/2014
1Exanthema (Rash)
03/2014
1Alopecia (Baldness)
03/2014
1Lymphadenopathy
03/2014
1Metabolic Diseases (Metabolic Disease)
09/2013
1Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
09/2013
1Spinal Cord Diseases
09/2012
1Neurosarcoidosis
07/2012
1Demyelinating Diseases (Demyelinating Disease)
02/2011
1Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
06/2010

Drug/Important Bio-Agent (IBA)

57Retinaldehyde (Retinal)IBA
11/2022 - 01/2011
8Biomarkers (Surrogate Marker)IBA
11/2022 - 09/2013
5Myelin-Oligodendrocyte GlycoproteinIBA
02/2022 - 01/2020
5MMEIBA
10/2019 - 04/2013
4Immunoglobulin G (IgG)IBA
01/2022 - 01/2020
2GlucocorticoidsIBA
11/2022 - 02/2021
2Neuroprotective AgentsIBA
01/2020 - 02/2012
1oligomycin sensitivity-conferring protein (complex V)IBA
11/2022
1Natalizumab (Tysabri)FDA Link
01/2021
1Glatiramer Acetate (Copaxone)FDA Link
01/2021
1Rituximab (Mabthera)FDA Link
01/2021
1CeramidesIBA
01/2021
1SphingolipidsIBA
01/2021
14-Aminopyridine (4 Aminopyridine)FDA Link
01/2020
1Aminobutyrates (Aminobutyric Acid)IBA
01/2020
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2020
1ocrelizumabIBA
05/2019
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
05/2019
1Complement System Proteins (Complement)IBA
01/2019
1Matrix Metalloproteinases (MMPs)IBA
01/2019
1melanopsinIBA
01/2017
1Phenytoin (Dilantin)FDA LinkGeneric
03/2016
1Indicators and Reagents (Reagents)IBA
11/2015
1Daclizumab (Zenapax)FDA Link
03/2014
1Membrane Proteins (Integral Membrane Proteins)IBA
09/2013
1Fatty Acids (Saturated Fatty Acids)IBA
09/2013
1Nitrous Oxide (Laughing Gas)IBA
09/2012
1AntigensIBA
03/2012
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
06/2010
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
06/2010

Therapy/Procedure

9Therapeutics
12/2021 - 01/2012
1Duration of Therapy
03/2014